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Abstract: Sisymbrium officinale (L.) Scop. is a wild common plant of the Brassicaceae family. It is known
as “the singers’ plant” for its traditional use in treating aphonia and vocal disability. Despite its wide
use in herbal preparations, the molecular mechanism of action of S. officinale extracts is not known.
The plant is rich in glucosinolates and isothiocyanates, which are supposed to be its active compounds.
Some members of this family, in particular allylisothiocyanate, are strong agonists of the transient
receptor potential ankyrin 1 (TRPA1) channel, which is involved in the somatosensory perception of
pungency as well as in the nociception pathway of inflammatory pain. This study aims to isolate the
glucosinolates and isothiocianates from fresh S. officinale to identify the major components and test
their activity in in vitro assays with a cloned TRPA1 channel. Samples of cultivated S. officinale have
been extracted and the active compounds isolated by column chromatography, HPLC and PTLC.
The main components glucoputranjivin, isopropylisothiocyanate and 2-buthylisothiocianate have
been tested on TRPA1. The glucosinolates glucoputranjivin and sinigrin turned out to be inactive,
while isopropylisothiocyanate and 2-buthylisothiocyanate are potent agonists of TRPA1, with an EC50
in the range of the high potency natural agonists identified so far for this somatosensory channel.
Keywords: Sisymbrium officinale; glucosinolates; isothiocyanates; TRPA1 ion channel; somatosensory
perception
1. Introduction
1.1. Sisymbrium officinale (Erysimum), “the Singers’ Plant”
Sisymbrium officinale (L.) Scop. (Brassicaceae) (SO) is an annual plant which is spread mostly
in the Eurasiatic Region and North Africa. It is very common in bare ground, on roadsides, dumps
and on the edges of fields. The plant is the object of a multidisciplinary project named “Erisimo a
Milano” studying its diffusion and ecology in North Italy, agronomic potential, phytochemistry and
food applications [1].
SO (also commonly named “erysimum” or “the singers’ plant”) is known for its traditional
use for vocal tract and other upper respiratory trait diseases. The chemical markers [2] of SO
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are glucosinolates (GLSs) and isothiocyanates (ITCs), also commonly found in mustard oil and
all brassicaceae. Historically, sulphured compounds are reputed to stimulate mucosal secretion
in the upper respiratory tract, increasing expectoration [3]. The pharmacological activity of SO shows
anti-inflammatory, analgesic, antitussive, myorelaxant [4] and broad-spectrum antimicrobial [5] activity
and also antimutagenic properties [6]. Its effect on alleviating vocal trait disability in a cohort of 104
patients showing various degrees of vocal trait discomfort has been recently reported [7].
Despite the millennia-held beliefs [8] and recent reports regarding the plant [7], a specific
mechanism of action for SO phytochemicals has not yet been described in the literature; thus,
the search for the specific mechanism of action of its components is an interesting target for
phytochemical research.
1.2. Glucosinolates and Isothiocyanates in SO
As in other plants, glucosinolates (GLSs) are present in SO with their corresponding ITCs, formed
by enzymatic hydrolysis by myrosinase and/or by chemical hydrolysis that could occur during the
plant manipulation, storage and processing. The formation of ITCs from GLSs via a Lossen’s type
rearrangement has been extensively reviewed [9–11]. The relative content of GLS and ITC is often
difficult to establish due to the dynamic equilibrium between the two classes of compounds and
to the very different chemical features of these functional groups; GLSs are quite polar and water
soluble, while ITCs are mainly low polar and volatile compounds. Analytical methodologies for
their determination are therefore different; UV spectroscopy and/or HPLC are mostly used for GLSs
analysis, while gas chromatography–mass spectrometry (GCMS) is more suitable for volatile ITCs.
The literature [12] identifies glucoputranjivin (compound 1, Figure 1) as the main glucosinolate in
SO; its corresponding isothiocyanate is isopropylisothiocyanate (IPITC, compound 2).
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In addition, 2-butylisothiocyanate (2-BITC, compound 4) from glucochoclearin 3 has been
previously identified in SO [5] b the GCMS of hydrodistillates. The presence of sinigrin 5 and
its corre pon i g allylisothiocyanate (AITC) 6 is contr versial; they ave bee identified i the fresh
plant [13] but in following report, they have been stated to be absent in SO [14]. N vertheless, sinigrin
5 is the only commercially available standard for GLS and theref re is universally used as the reference
compound for the qualitative and qu ntit tive determination of GLSs in SO extracts [12], used also in
t e French pharmac pea method [15].
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AITC 6 from sinigrin is the molecular marker of sinapis; it is responsible for the pungency and
irritation of many food plants including mustard, wasabi and many others. AITC is also the reference
compound to test the activity of chemicals on the TRPA1 somatosensory channel.
1.3. TRPA1 Channel as the Target of Pungent Principles in Plants
The TRPA1 channel is a protein in the family of transient receptor potential ion channels.
Previously called ANKTM1 (ankyrin repeat-containing ion channel 1), TRPA1 is the only member
of the TRPA sub-family reported in mammals [16]. TRPA1 is a polymodal sensor involved in the
somatosensory perception of several stimuli, among which are cold, pungent compounds, airborne
irritants and cannabinoids, as well as finding use in audition, proprioception, neurogenic inflammatory
responses and pain perception [17,18]. TRPA1 is expressed in the dorsal root ganglion (DRG),
vagal ganglion (VG), nodose and trigeminal ganglion (TG) neurons [19]. It has been reported that
TRPA1 is also expressed in non-neural cells that are also relevant for chemosensation such as skin
keratinocytes [20,21] and airway epithelial cells [22].
TRPA1 is activated by a large number of chemicals found in many plants, food, cosmetics, and
pollutants. Electrophilic, pungent compounds such as unsaturated aldehydes, ketones, isothiocyanates,
and thiosulfinates can be found in many plants, and particularly in Brassicaceae. These plants (cabbage,
broccoli, cauliflower, mustard, horseradish, radish, wasabi, and many more) are important crops
for human and animal diets; many of them, including SO, are also commonly used as traditional
remedies. Allylisothiocyanate (mustard oil) and derivatives such as benzyl-, phenylethyl-, isopropyl-,
and methyl-isothiocyanates are the main pungent ingredients inducing TRPA1 activation [23].
1.4. Aim of This Work
Basing on the evidence emerging from the literature that TRPA1 agonists have a role in mediating
anti-inflammatory and/or analgesic effects [24,25], a possible involvement of this channel in the
pharmacological mechanism of SO extracts can be envisaged. To test this hypothesis, the aim of
this work is to isolate single compounds from SO and to submit them to in vitro assays with cloned
TRPA1 receptor in order to verify the presence of effective agonists in the plant. Both glucosinolates
and isothiocyanates were isolated and tested. Glucoputranjivin 1, the main GLS from SO, was also
synthesised in order to obtain larger amounts of the compound, to confirm its structure and to use it as
a standard for analytical purposes.
2. Results
2.1. Preliminary Analysis of SO Volatiles
A preliminary analysis was performed with the aim of identifying the main volatile compounds
and particularly the isothiocyanates in our samples. Volatile profiles of SO plants were obtained
by solid-phase micro extraction (HS-SPME) coupled with gas chromatography–mass spectrometry
(GCMS).
Hydrolysis products of glucosinolates were extracted and analyzed following literature
methods [26,27].
For SPME sampling, fresh leaves were put in a vial and rapidly mashed and crushed, had water
added, stoppered with a screw cap equipped with septa, and then an SPME fiber was inserted into the
sample headspace to be analyzed by GCMS. These conditions were adopted to simulate the mastication
process of fresh leaves, releasing myrosinase from the tissues in the oral cavity and hydrolyzing the
glucosinolates to the corresponding volatile isothiocyanates. ITCs are then perceived in the oral cavity
due to their pungency, mediated by the TRPA1 receptor. In our experimental conditions, the volatile
ITCs were analyzed by GCMS and identified basing on their retention time, mass spectrum and by
comparison with the commercially available standards.
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Results show that ITCs account for the major proportion in volatiles. Hydrolysis mainly leads
to IPITC (compound 2), followed by 2-BITC (compound 4). The percentage of the two compounds
varies in different samples, with compound 2 always being the main component in leaves, seeds
and flowers; compound 4 is present in variable amounts, reaching 24% of total volatiles in a sample
of fresh flowers [28]. The compound 2-BITC is the hydrolysis product of glucochoclearin 3; it is
abundant in plants of the genus Cochlearia and has been previously found also in SO [5]. The sum
of allylisothiocyanate, methylisothiocyanate and other isothiocyanates accounts for only about 1% of
total volatiles. This result confirms that sinigrin can be present in SO as a minor component.
2.2. Isolation and Synthesis of Glucoputranjivin 1
For the isolation of GLSs, extracts of SO were prepared following the literature procedure [15]
starting from dry plant material. A preliminary analysis showed that the seeds are more easily purified
compared to leaves and flowers; therefore, the isolation of 1 was made from seeds. The extracts were
purified by column chromatography, followed by PTLC. We obtained 8.5 mg of compound 1 with a
purity estimated at about 94% by HPLC. The structure of glucoputranjivin 1 was confirmed by 1H
and 13C-NMR spectroscopy and by comparison of spectral data to those of the desulfo-corresponding
compounds described in the literature [29] and with those of the analogous glucocochlearin [30].
The NMR data obtained are shown in Table 1.
Table 1. 1H and 13C data for glucoputranjivin 1 in MeOH-d4 at 25 ◦C.
C Assignment δC (ppm)
δH (ppm, Molteplicity,
(J in Hz))
Aliphatic moiety
1 C 165.68
2 CH 34.03 2.97, m (6.90)
3 CH3 21.33 * 1.298 *, d (6.90)
4 CH3 22.45 * 1.296 *, d (6.90)
Glucose moiety
1’
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Despite many attempts, we could not isolate co pound 3 in our samples, even if its presence
is strongly suggested by the concomitant pre e of its derivative ITC in the volatile fraction.
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and was used to establish the relative efficacy for each tested compound. Antagonist/desensitizing
behavior was also measured. The results of in vitro assays of isolated compounds are shown in Table 2.
Table 2. In vitro assays of isolated compounds on transient receptor potential ankyrin 1 (TRPA1)
receptor.
TRPA1
cpd Name Efficacy(%AITC 100µM)
Potency
EC50 µM
IC50 Inhibition
TRPA1 µM
(AITC 100µM)
5 (−)-Sinigrin <10 NA >100
1 Gluco-putranjivine <10 NA >100
2 Isopropylisothiocyanate 108.8 ± 1.6 5.9 ± 0.4 10.8 ± 0.4
4 2-buthylisothiocyanate 98.0 ± 1.0 4.9 ± 0.2 12.1 ± 0.2
TRPA1-human embryonic kidney (HEK)-293 cells exhibited a sharp increase in intracellular Ca2+
upon application of the compounds examined—that is, 2 and 4—with efficacies of 108.8 and 98.0,
respectively, and EC50 values < 6 µM (Figure 2, panel a). Both 2 and 4 at 100 µM showed no activity
(no elevation of internal Ca2+) on not-transfected HEK cells (with an activity less than 1%).
Five minutes of preincubation of TRPA1-HEK-293 cells with ITCs 2 and 4 followed, and then
incubation was continued with AITC, causing the inhibition of TRPA1 response to this agonist with
IC50 values of 10.8 and 12.1 µM, respectively (Figure 2, panel b). Then, upon activation, calcium
enters the cell and stimulates a series of calcium-dependent processes that ultimately lead to the
desensitization of the TRPA1 channel. Upon desensitization, the TRPA1 channel enters a refractory
period in which it can no longer respond to agonist (AITC) stimulation. The EC50 and IC50 values were
comparable, of the same order of magnitude. This implies that ITCs 2 and 4 desensitize the receptor to
the next AITC action leading to a paradoxical inhibitory effect of these compounds.
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Figure 2. Panel (a): dose-related effect of isopropylisothiocyanate (IPITC) and 2-butylisothiocyanate
(2-BITC) on el vation of intracellular Ca2+ in human embryonic kidney (HEK)-293 cells stably
transfected with rat TRPA1 (rTRPA1-HEK-293). Data are expressed as percentages of the effect ob erved
with allylisothiocyanate (AITC, 100 µM). Panel (b): dose- lated ff ct of 5-min pre-incubation of
rTRPA1-HEK-293 cells wi IPITC and 2-BITC on the AITC (100 µM)-induced elevation of intracellular
Ca2+. Data are expressed as percentages of the effect observed wi AITC (10 µM) alone.
3. Discussion
The use of SO extracts for voice care is widespread. Singers, actors and other professional users of
the voice use commercial products containing SO (often in combination with other botanicals) for this
purpose, and recently clinical studies [7] confirmed its efficacy in the treatment of vocal discomfort.
Despite the long history of use and the phytochemical knowledge of Sisymbrium, its mechanism
of action on the voice is still unclear. The effect on pharyngeal irritation is suggested to be related to
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the content of mucilage (10.9–13.5%) [7], and Di Sotto [14] highlighted that the extract of Sisymbrium
officinale possesses a myorelaxant activity, particularly against the agents involved in the inflammatory
process. Nevertheless, a specific biological target for its active principles has never been identified.
Several literature reports confirm that the TRPA1 ion channel is a polymodal sensor involved
in mediating inflammatory pain signals. Plenty of plants containing TRPA1 agonists are used for
their anti-inflammatory and/or anti-nociceptive features, among which are turmeric, cinnamon, clove,
ginger and many more.
Plants in the Brassicaceae family are rich in TRPA1 active compounds, and some of them
are already recognized as potent agonists, as with the AITC contained in mustard. Also, other
isothiocyanate compounds, including benzyl-, phenylethyl-, isopropyl- and methylisothiocyanate,
have been previously shown to activate the human TRPA1 channel by calcium imaging, but the activity
was expressed only as a range [23,25,32].
Our results indicate that both the ITCs contained in SO are potent agonists of the TRPA1 ion
channel. In vitro, the efficacy of IPITC (compound 2) is even higher than that of AITC, the reference
standard compound for this chemical class. Compound 4, 2-BITC, has been tested for the first time
and its efficacy turned out to be high as well, although a little lower than that of AITC.
The potency values of the two ITCs from SO have been compared to that of many natural agonists
of the TRPA1 ion channel owing to their different chemical families, which have been recently reported
by some researchers [33] (Figure 3).
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Figure 3. Comparison between TRPA1’s activity of ITC from Sisymbrium officinale (L.) Scop. and other
natural known agonists. Potency is expressed as 1/EC50; EC50 values are given in microM units.
Compounds described in this paper are shown in black.
The two ITCs that are present in SO extracts are among the highest-potency agonists, which
include oleocanthal, curcumin and umbelliferone, whereas other well-known agonists such as
cynnamaldehyde and 6-gingerol are less potent.
The involvement of sulphur derivatives in the therapeutic action of SO, as well as of many other
medicinal plants in the Brassicaceae family, is usually expressed as a matter of fact. The total amount
of GLSs in the plant and in commercial phytopreparations (usually expressed as sinigrin equivalents)
is measured in French Pharmacopea as an index of the “goodness” of phytopreparates; this implies
that GLSs are considered to be the active principles. Accordingly, traditional use suggests that the
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more efficient parts of the plant are the top edges and flowers, where the amount of GLSs is higher.
Nevertheless, to our knowledge, there is no direct evidence that these sulphur compounds could exert
a specific pharmacological activity on vocal traits.
Our data support the hypothesis that ITC compounds 2 and 4 could be among the active principles
in SO, indicating the TRPA1 ion channel as the molecular target of their pharmacological action in vitro.
In our assays on the TRPA1 channel, the glucosinolates sinigrin 5 and glucoputranjivin 1 were
shown to be ineffective per se. Since the active ITCs are produced in situ by GLS hydrolysis, this finding
supports the idea that the efficacy of plant preparation is positively associated with high GLC content
in the plant, which corresponds to a high content in ITCs. Furthermore, this result indicates that the
method used for processing and assuming the plant material could be relevant in determining the final
content in active phytochemicals and therefore the efficacy of therapeutic action.
The availability and use of pure glucoputranjivin 1 as a reference compound (instead of sinigrin)
is very useful for qualitative and quantitative determinations of active compounds in SO; in fact,
compound 1 shows the most abundant GLS in all parts of the plant, whereas sinigrin is usually absent
or present only in traces.
The potential of active compounds from SO for applications in voice care represents an interesting
topic for further studies. Despite the fact that professional vocalists are a numerically small population
and that vocal problems are usually minor pathologies, the protection of the voice and the maintenance
of its performance are still important targets for artists and therefore have a high intrinsic value.
The market demand for natural remedies is rapidly growing, but very often research data
demonstrating the real pharmacological activity of single molecules are lacking.
The involvement of TRPA1 in one of the possible mechanisms involved in the effects on
voice care of SO extracts must of course be confirmed by further in vivo and clinical experiments.
The identification of active ITCs from “the singers’ plant”, their molecular targeting and in vitro
measurable effects are results which can contribute to clarifying its real potential and to addressing its
uses and applications.
4. Materials and Methods
4.1. Plant Material
Sisymbrium officinale was cultivated at the Faculty of Food and Agricultural Sciences at the
University of Milano [34]. Plants were harvested during the flowering season (May–July 2017 and
2018) and seeds collected in August, September and October 2017 and 2018. The aerial parts (leaves,
flowers) of the plant were dried at room temperature and stored in paper bags. Seeds were stored in
a vacuum at 4 ◦C. For the GCMS headspace analysis of volatiles, samples were harvested from the
living plant and used immediately.
4.2. Chemicals and Equipment
Sinigrin monohydrate (potassium salt) (CAS 3952-98-5), isopropylisothyocianate (2253-73-8),
2-butylisothiocianate (4426-79-3), methanol and acetonitrile were from Sigma-Aldrich (Milan, Italy).
Thin-layer chromatography (TLC) was performed on silica gel 60 F254 plates (Sigma-Aldrich,
Italy) and developed using n-butanol/acetic acid/water 4:1:4 (v/v/v) as a mobile phase. The spots
were visualized under UV light at 254 nm and then sprayed with a solution of thymol 1% and sulphuric
acid 10% in ethanol. Sinigrin was used as a reference for GLSs; it gave a pink spot with Rf 0,2 after
heating, while glucoputranjivine gave a blue–violet-colored spot (Rf 0,18).
NMR spectra were recorded on a Bruker Avance spectrometer (Bruker BioSpin GmbH,
Rheinstetten, Germany) operating at 600 MHz, using MeOH-d4 as a solvent and TMS as an internal
standard; J values are given in Hertz.
HPLC analysis were performed with a liquid Chromatograph Dynamax SD200 (VARIAN®,
Woburn, MA, US), equipped with a binary pump with Rheodyne injector and a UV-VIS detector
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managed by the Galaxy chemstation (VARIAN®, Woburn, MA, US). A reversed phase column C18
Lichrosphere (250 mm length, 4.6 mm ID, 5 µ, Phenomenex®) was used. The samples were dissolved
in methanol and filtered with 0.45 µm nylon filters. The conditions used were the following: flow
0.7 mL/min, λ 227 nm; solution A ammonium acetate 0.01 M; solution B acetonitrile; gradient elution:
t 0–10min: 100% A; t 10–15 min: A 95%, B 5%; t 15–25 min: A 95%, B 5%; t 25–45 min: A 30%, B70%.
4.3. HS- SPME Coupled with GCMS Analysis
Autolyzed samples were prepared by crushing 0.5 g of flowering sample plants with 1 mL of
H2O in a 20 mL vial (Agilent Technologies, Santa Clara, CA, US), which was rapidly sealed with a
magnetic screw cap equipped with silicon/polytetrafluoroethylene septa (PTFE).
Headspace (HS) volatile compounds were collected using a SPME fiber (Supelco, Darmstad,
Germany) 2 cm × 50/30 m thickness coated with DVB/CAR/PDMS (Divinylbenzene/Carboxen/
Polydimethylsiloxane). Initially, vials were tempered at 37 ◦C for 2 min. Then, the volatiles were
extracted by exposing the fiber to the vial headspace for 10 min under continuous agitation and
heating at 37 ◦C. The extracted volatiles were desorbed in the GC injection port for 2 min at 230 ◦C in a
splitless mode. The incubation of the vials, extraction, and desorption of the volatiles were performed
automatically by a CombiPAL autosampler (CTC Analytics, Zwingen, Switzerland). Chromatography
was performed on a DB-5 MS (30 m × 0.25 mm × 0.25 µm) column (Agilent J&W Capillary columns,
Santa Clara, CA, US) with helium as carrier gas at a constant flow of 1.0 mL/min. The GC interface,
MS source and quad temperatures were 260 ◦C, 230 ◦C and 150◦ C, respectively. The oven temperature
conditions were 40 ◦C for 3 min, a 5 ◦C/min ramp until 250 ◦C, and then held at 250 ◦C for 5 min.
Mass spectra were recorded in scan mode in the 30 to 300 mass-to-charge ratio range by a 5975B
mass spectrometer (Agilent Technologies) at an ionization energy of 70 eV and a scanning speed of
7 scans/s. Chromatograms and spectra were recorded and processed using the Enhanced ChemStation
software (Agilent Technologies). GCMS total ion chromatogram (TIC) and mass spectra are available
as Supplementary Materials (S1, S2).
4.4. Glucoputranjivin, Isolation and Purification
Glucoputranjivin 1 was obtained from seeds. 10.3 grams of seeds were extracted with 200 mL
of 80% MeOH at 80 ◦C for 30 min. After the first extraction, the seeds were shredded in a mortar
and extracted again with hot MeOH (160 mL for 30 min). After the evaporation of the solvent in a
vacuum, 992.5 mg of crude extract were obtained. The crude extract was purified by two subsequent
flash column chromatographies (DCM/MeOH 60:40). From the second column, only one fraction
(43.5 mg), the richest in glucoputranjivin, was submitted to purification by PTLC (DCM/MeOH 65:35)
to give compound 1 (8.5 mg) with a purity >90% by HPLC and NMR. Compound 1 (19 mg) was
synthesized by the literature method [31] (Supplementary Material, Figure S3); the purity was >90%
(HPLC, Figure S5). Intermediate compounds in the synthesis have already been described in the
literature [31,35]; experimental analytical data are available in Supplementary Materials (S4).
Compound 1 is an amorphous solid; m/z: HRMS m/z (C10H18NO9S2): 360.0421 (100%, M+),
361.0450 (12%, M + 1), 362.0395 (10%, M + 2), 336.3266 (30%); calculated mass: 360.0423. IR (ν, cm−1)
1572.18 (-C=N-), 1272.29 (-O-SO3−). 1H and 13C NMR data are reported in Table 1; full spectra are
reported in Supplementary Material S6–S9.
4.5. In Vitro Assays with rTRP Ion Channels
Compound effects on intracellular Ca2+ concentration ([Ca2+]i) were determined using the
selective intracellular fluorescent probe Fluo-4. Assays of the rat TRPA1-mediated elevation of
intracellular Ca2+ in transfected HEK-293 cells were performed as described [36]. Briefly, human
embryonic kidney (HEK-293) cells (stably transfected with rat TRPA1 or not transfected) were cultured
in EMEM + 2 mM Glutamine + 1 % non-essential amino acids (NEAA) + 10 % FBS and maintained at
37 ◦C with 5 % CO2. On the day of the experiment, the cells were loaded with Fluo-4 AM (4 µM) for
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1 h at room temperature, rinsed and resuspended in Tyrode’s solution (145 mM NaCl, 2.5 mM KCl,
1.5 mM CaCl2, 1.2 mM MgCl2, 10 mM d-glucose, and 10 mM HEPES, pH 7.4), and finally transferred to
a quartz cuvette of a spectrofluorimeter (Perkin-Elmer LS50B, Perkin Elmer Inc, Buckinghamshire, UK);
λEX = 488 nm, λEM = 516 nm) equipped with a PTP-1 Fluorescence Peltier System (PerkinElmer Life
and Analytical Sciences, Waltham, MA, USA) under continuous stirring. Cell fluorescence before and
after the addition of various concentrations of test compounds was measured, normalizing the effects
against the response to ionomycin (4 µM). The values of the effect on [Ca2+]i in not-transfected HEK-293
cells were used as a baseline and subtracted from the values obtained from transfected cells. Agonist
efficacy was expressed as a percentage of the effect on [Ca2+]i observed with 100 µM allylisothiocyanate
(AITC). The potency of the compounds (EC50 values) was determined as the concentration required to
produce half-maximal increases in [Ca2+]i. Antagonist/desensitizing behavior as evaluated against
TRPA1 agonist AITC 100 µM by adding the compound directly into the quartz cuvette 5 min before
the stimulation of cells with the agonist. IC50 is expressed as the concentration exerting a half-maximal
inhibition of an agonist effect, taking as 100% the effect on [Ca2+]i exerted by the agonist alone.
Dose–response curves are fitted by a sigmoidal regression with a variable slope. Curve fitting and
parameter estimation were performed with a GraphPad Prism (GraphPad Software Inc., San Diego,
CA). Three independent experiments were done for each determination; all determinations were
performed at least in triplicate. The time-course spectra showing the increase of intracellular Ca2+
upon application of the compounds are available in Supplementary Material (S10).
Supplementary Materials: The following are available online. Figure S1: GCMS Total Ion Chromatogram (TIC)
of volatiles in SO. Figure S2: Mass spectra of volatiles in SO. Figure S3: synthetic scheme for the synthesis of
glucoputranjivine. Figure S4: analytical data for intermediates in the synthesis of glucoputranjivin. Figure S5:
HPLC chromatogram of compound 1. Figure S6: 1HNMR spectra of compound 1. Figure S7: 13CNMR spectra
of compound 1. Figure S8: HRMS spectra of compound 1. Figure S9: IR spectrum of compound 1. Figure S10:
Representative traces of [Ca2+]i increase evoked by IPITC (a), 2-BITC (b) and AITC (c, for comparison) at 100 µM
in HEK293 cells over-expressing rat TRPA1.
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